Rottenstein Law Group Reports On

New York, NY (PRWEB) July 03, 2012

The Rottenstein Law Group, which represents clients with claims stemming from injuries and birth defects caused by the Selective Serotonin Reuptake Inhibitors (SSRIs) Zoloft and Paxil, has learned of research suggesting that critically ill patients who are prescribed SSRIs after being admitted a hospital's intensive care unit (ICU) are more likely to die than patients who are not taking a drug in the SSRI class.

According to a release issued by the American Thoracic Society, a group of researchers from Beth Israel Deaconess Medical Center in Boston, and the Massachusetts Institute of Technology conducted a study that looked at the medical records of 10,568 patients one year after being admitted to the ICU. Of the 10,568 patient records studied, 1,876 were taking either an SSRI or a serotonin and norepinephrine reuptake inhibitor (SNRI) prior to admission to the ICU. They were compared to other patients admitted to the ICU who were not taking one of those medications. After making adjustments for age, gender, diagnosis, illness severity and other factors, the researchers determined that patients on SSRI/SNRI's prior to admission to the ICU were 73% more likely to die in the hospital.

Among patient groups, risk was highest among those with acute coronary syndrome and those who had undergone cardiac surgery. For both of these patient groups, the risk of dying in the hospital was more than double if they were taking an SSRI or an SNRI prior to admission.

"We found that mortality was higher overall for patients taking antidepressants prior to admission to the ICU and remained significantly higher a year later," says Dr. Katherine. M. Berg, one of the physicians involved in the study, in the American Thoracic Society release. "We also found that certain subgroups of patients, particularly patients admitted for cardiac problems, appeared to be at even greater risk."

The Rottenstein Law Group?s Zoloft Lawsuit Information Center contains social media features that allow for easy sharing on sites like Facebook and Twitter, which enables visitors to spread the word about the potential dangers associated with Zoloft. The firm encourages visitors to link to its sites from their own blogs and Web sites to spread information about dangerous drugs and defective medical devices.

If you took Zoloft and you believe it caused you to suffer harm, or if you took Zoloft while you were pregnant and you believe it caused harm to your unborn baby, your unborn baby, visit RLG's Zoloft Birth Defects Information Center.

About the Rottenstein Law Group

The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.

###

Beyond Managed Care: How Consumers and Technology Are Changing the Future of Health Care

A guidebook for preparing for the next phase in the evolution of health careBeyond Managed Care—written by a distinguished group of health care experts-offers an insightful analysis of the dynamics of the health care marketplace from the perspective of consumers and purchasers. Written for health care leaders at all levels, Beyond Managed Care identifies and assesses the key factors most likely to influence the future market for health care services-such as consumer empowerment through the Internet and the increasing demands of the aging baby boomer population-and shows providers what adjustments can be made in order to thrive in this emerging environment. The authors analyze the factors driving health care costs such as changing demographics, new medical technology, genetic and new drug research, and payment system models. The book clearly shows that organizations that are able to take organizations to the next value-added level-by providing quality, access, service, innovation, and lower costs-will be the winners."Picks up where Paul Starr's Social Transformation of American Medicine left off, and will soon become a classic of equal stature."—Anne Ladd, product manager, Physician Market, Micromedex, Englewood, Colorado"The authors will enlighten and entertain you—and challenge your current mental model of health care. Their discussion of the Internet and clinical information technology is worth the price of the book."—Leland R. Kaiser, president, Kaiser Consulting, Brighton, Colorado"A thorough review of a complex subject, and done in a way that is easily accessible. The scenarios represent a valuable starting point for health care leaders to begin to dialogue and learn about where health care may be headed."—John Koster, M.D., senior vice president/chief medical officer, Sisters of Providence Health System, Seattle, Washington"Provides great historical perspective on the changes that health care has experienced, but more impo


Price: $ 0.01

Sold by Barnes & Noble

Journal of Drug Delivery Science and Technology C-W Stp Phar

Supercritical Fluid Technology For Drug Product Development (Drugs and the Pharmaceutical Sciences)
Interconnecting the fundamentals of supercritical fluid (SCF) technologies, their current and anticipated utility in drug delivery...

Epson Stylus NX625 Wireless All-in-One Color Inkjet Printer, Copier, Scanner (C11CA70271)
With built-in wireless printing and automatic two-sided printing, the Epson Stylus NX625 makes it easy to take on all your everyda...

| cheap carpets | Spirometer | Rubber Flooring Choices | | Deciding on the Correct Embroidery Sewing Machine | Scotland Festival - The In Depth Overview Of What Actually | Cleaning NJ 97 | Sweet anti fatigue mats Secrets You Aren't Use Anti-Fatigue Matting | Plumbing Problems Clogging Up Your Time? Help Is Here!